Mitral annular calcification (MAC) is a common condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. It can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure. In this article, we will explore the impact of MAC on heart health, and discuss how it can be managed.
Mitral annular calcification is a condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. The mitral valve is a one-way valve that prevents blood from flowing backwards into the left atrium. When calcium builds up around the valve, it can cause it to become stiff and narrow, making it difficult for the valve to open and close properly. This can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure.
There are several risk factors that may increase the likelihood of developing MAC. These include: • Age: MAC is more common in older individuals, and the risk increases with age. • Gender: Women are more likely to develop MAC than men. • Hypertension: High blood pressure can increase the risk of developing MAC. • Diabetes: People with diabetes are more likely to develop MAC. • Smoking: Smokers are more likely to develop MAC than non-smokers. • Family history: Having a family history of MAC may increase the risk. • Diet: A diet high in saturated fats and low in calcium and vitamin D can increase the risk of MAC.
The symptoms of MAC vary from person to person, but can include: • Shortness of breath • Fatigue • Palpitations • Chest pain • Swelling of the feet and ankles • Dizziness or fainting • Irregular heartbeat
The diagnosis of MAC is typically made using echocardiography, a type of ultrasound that uses soundwaves to create images of the heart. Other tests, such as a chest X-ray, electrocardiogram, or cardiac catheterization, may also be used to diagnose MAC.
The treatment of MAC depends on the severity of the condition. In some cases, lifestyle changes, such as quitting smoking, controlling blood pressure, and eating a healthy diet, may be enough to manage the condition. In more severe cases, medications, such as diuretics, ACE inhibitors, and beta blockers, may be prescribed to reduce the risk of complications. In some cases, surgery may be necessary to repair or replace the mitral valve.
Mitral annular calcification is a common condition in which calcium deposits accumulate around the heart's mitral valve. It is a degenerative process that is seen in elderly patients, and is often associated with cardiovascular disease. It can lead to a number of health problems, including an increased risk of stroke, heart attack, and heart failure. The risk factors, symptoms, diagnosis, and treatment of MAC will vary from person to person, but it is important to be aware of the condition and take steps to manage it.
1.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
2.
Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.
3.
AI catches one-third of interval breast cancers missed at screening
4.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
5.
Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says
1.
Lymphomatoid Papulosis: What You Need to Know
2.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
3.
The Rise of Immunotherapy: New Advances in Cancer Treatment
4.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
5.
Patient Management Following Organ-Preserving Cancer Interventions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation